Pharmacyte Biotech Inc (OTCMKTS:PMCB) a biotechnology firm in clinical stage reported that effective July today, American Stock Transfer & Trust Company will act as new stock transfer and dividend distributing agent. Prior to AST, Signature Stock Transfer used to work as stock transfer agent for the company.
The expert view
Expressing his views on the new engagement of stock transfer agent, Pharmacyte Biotech CEO, Kenneth L. Waggoner, said that they are extremely delighted to report the appointment of AST as company’s new stock transfer agent. They are confident that this new partnership will provide shareholders with excellent customer service and support.
Moreover, the new association will enable company to have access to leading management resources. It will work as a strong platform to achieve the highest quality of operational procedure that can result in tangible financial benefits to company and its shareholders.
The new stock transfer agent AST is a leading provider firm of registry services and technology to financial market entities across the globe. With more than forty years of experience, it is known for offering excellent customer service experience, well supported by investments to people, technology and service offerings. The transfer agent has innovative software, premier in-house call centers, and processing systems that define the industry standard.
Pharmacyte revealed that AST offers comprehensive employee plan and stock transfer services to more than 2,800 public firms and maintains almost 6,000 issues. Its clients are based throughout the U.S. and in more than 22 foreign nations, ranging in size from IPOs to Fortune hundred companies. AST was established in 1971 and is headquartered in New York. Effective today, all correspondence and inquiries related to transfer of shares, stockholder records, dividend checks, lost certificates, or change of address would be directed to AST.
Pharmacyte Biotech Inc (OTCMKTS:PMCB) wiped out almost the entire loss incurred in the last two sessions and ended the last trading session with a solid gain of 10.89%. The high of the day at $0.1190 took place in a very strong resistance area, which if broken in the next few sessions, can trigger a rally towards the major resistance area around $0.16. The volume of the last session at 3 million was just over the daily average of 2.6 million, showing the presence of some buyers. The bounce back from the major support zone just below $0.10 strengthens up the bullish possibilities in the short term.